Australia-United States Free Trade Agreement and the Pharmaceutical Benefits Scheme
(Redirected from United States-Australia Free Trade Agreement and the Pharmaceutical Benefits Scheme)
Jump to navigation
Jump to search
Other SourceWatch resources
- Australian Government
- Australia-United States Free Trade Agreement
- Australia-United States Free Trade Agreement Business Group
- Anne Wexler
- Pharmaceutical Benefits Scheme
- Wexler and Walker Public Policy Associates
- Bergner, Bockorny, Castagnetti, Hawkins & Brain
- Alan Oxley
External links
- Steve Lewis, "FTA drug safeguard at risk", The Australian, January 3, 2006.
- "Medicine costs won't rise: govt", The Age, January 3, 2006.
- Jeremy Thompson, "Drug companies pressure Govt to review FTA", "7.30 Report", ABC TV, January 3, 2006.
- Steve Lewis, "Cost of drugs 'to rise' in FTA plan", The Australian, January 4, 2006.
- Thomas Faunce and Andrew Searles, "Warning: giving in to the US may have serious side effects", Sydney Morning Herald, January 4, 2006.
- Mark Metherell, "Lack of drug subsidies may threaten supply", Sydney Morning Herald, January 4, 2006.
- Brendan Grabau, "FTA does not endanger prices", Australian Financial Review, January 17, 2006.
- Patricia Ranald, "Don't underrate evergreening dangers", Australian Financial Review, January 20, 2006.
| This article is a stub. You can help by expanding it. |
